Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia

被引:162
作者
Rijneveld, AW
Levi, M
Florquin, S
Speelman, P
Carmeliet, P
van der Poll, T
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Expt Internal Med, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands
[5] Flemish Interuniv Inst Biotechnol, Ctr Transgene Technol & Gene Therapy, Louvain, Belgium
关键词
D O I
10.4049/jimmunol.168.7.3507
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cell recruitment is a multistep process regulated by cytokines, chemokines, and growth factors. Previous work has indicated that the urokinase plasminogen activator receptor (uPAR) may also play a role in this mechanism, presumably by an interaction with the beta(2) integrin CD11b/CD18. Indeed, an essential role of uPAR in neutrophil recruitment during pulmonary infection has been demonstrated for beta(2) integrin-dependent respiratory pathogens. We investigated the role of uPAR and urokinase plasminogen activator (uPA) during pneumonia caused by a beta(2) integrin-independent respiratory pathogen, Streptococcus pneumoniae. uPAR-deficient (uPAR(-/-)), uPA-deficient (uPA (-/-)),and wild-type (Wt) mice were intranasally inoculated with 10(5) CFU S. pneumoniae. uPAR(-/-) mice showed reduced granulocyte accumulation in alveoli and lungs when compared with Wt mice, which was associated with more S. pneumoniae CFU in lungs, enhanced dissemination of the infection, and a reduced survival. In contrast, uPA(-/-) mice showed enhanced host defense, with more neutrophil influx and less pneumococci in the lungs compared with Wt mice. These data suggest that uPAR is necessary for adequate recruitment of neutrophils into the alveoli and lungs during pneumonia caused by S. pncumoniae, a pathogen eliciting a beta(2) integrin-independent inflammatory response. This function is even more pronounced when uPAR is unoccupied by uPA. The Journal of Immunology, 2002, 168: 3507-3511.
引用
收藏
页码:3507 / 3511
页数:5
相关论文
共 41 条
[1]  
Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
[2]   Urokinase-type plasminogen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice [J].
Beck, JM ;
Preston, AM ;
Gyetko, MR .
INFECTION AND IMMUNITY, 1999, 67 (02) :879-884
[3]   Integrin-dependent induction of functional urokinase receptors in primary T lymphocytes [J].
Bianchi, E ;
Ferrero, E ;
Fazioli, F ;
Mangili, F ;
Wang, J ;
Bender, JR ;
Blasi, F ;
Pardi, R .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (05) :1133-1141
[4]   uPA, uPAR, PAI-I: key intersection of proteolytic, adhesive and chemotactic highways? [J].
Blasi, F .
IMMUNOLOGY TODAY, 1997, 18 (09) :415-417
[5]   The urokinase receptor. A cell surface, regulated chemokine [J].
Blasi, F .
APMIS, 1999, 107 (01) :96-101
[6]  
Blasi Francesco, 1999, Biochimica et Biophysica Acta, V1423, pR35, DOI 10.1016/S0304-419X(98)00034-1
[7]  
BOYLE MDP, 1987, J IMMUNOL, V139, P169
[8]   P-SELECTIN ICAM-1 DOUBLE MUTANT MICE - ACUTE EMIGRATION OF NEUTROPHILS INTO THE PERITONEUM IS COMPLETELY ABSENT BUT IS NORMAL INTO PULMONARY ALVEOLI [J].
BULLARD, DC ;
QIN, L ;
LORENZO, I ;
QUINLIN, WM ;
DOYLE, NA ;
BOSSE, R ;
VESTWEBER, D ;
DOERSCHUK, CM ;
BEAUDET, AL .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1782-1788
[9]   PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[10]   Inhibitory role of plasminogen activator inhibitor-1 in arterial wound healing and neointima formation - A gene targeting and gene transfer study in mice [J].
Carmeliet, P ;
Moons, L ;
Lijnen, HR ;
Janssens, S ;
Lupu, F ;
Collen, D ;
Gerard, RD .
CIRCULATION, 1997, 96 (09) :3180-3191